公司资料
BioRestorative 股价、新闻与催化剂
- 股票代码:
- BRTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.22 USD (-2.40%)
收盘价
最后更新: 2026年8月21日
9.03M USD
市值
股价为何变动
As of Aug 21, 2026, BRTX closed down 2.40% at $0.2153. No new same-company headline was identified in the current news window.
公司概览
业务概览
BioRestorative Therapies is a regenerative medicine company focused on cell therapies and musculoskeletal repair. Its business centers on using biologic approaches to address spine and orthopedic conditions.
所在地与行业分类
BioRestorative is headquartered in the United States and listed on NASDAQ. It sits in regenerative medicine and small-cap biotech.
商业模式特征
The company depends on translational progress, platform validation, and financing to keep development moving. Investors typically watch preclinical or early clinical updates and the company's ability to prove a commercially relevant use case.
生物医药行业定位
BioRestorative occupies a speculative regenerative-medicine niche within biotech. The stock is driven by platform credibility and the ability to turn cell therapy into a practical treatment path.
未来催化剂
- BioRestorative’s catalysts are regenerative medicine, spinal-disc programs, and any update that shows the platform still has a path. The company remains highly dependent on clinical progress.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。